top
BRAINLIFE NEWSLETTER
Volume 3, Number 25 - 7 July 2004

Volume 3
Archive


Contents


Diagnosis & Evaluation
Etiology & Pathogenesis
Overall Management
Treatment

Diagnosis & Evaluation


Murphy PS, Viviers L, Abson C, Rowland IJ, Brada M, Leach MO, Dzik-Jurasz AS
Monitoring temozolomide treatment of low-grade glioma with proton magnetic resonance spectroscopy
Br J Cancer. 2004 Feb 23;90(4):781-6. (Clinical Study, Abstract)


Etiology & Pathogenesis


Losa M, Vimercati A, Acerno S, Barzaghi RL, Mortini P, Mangili F, Terreni MR, Santambrogio G, Giovanelli M
Correlation between clinical characteristics and proliferative activity in patients with craniopharyngioma
J Neurol Neurosurg Psychiatry. 2004 Jun;75(6):889-92. (Laboratory Investigation, Abstract)

Moroni I, Bugiani M, D'Incerti L, Maccagnano C, Rimoldi M, Bissola L, Pollo B, Finocchiaro G, Uziel G
L-2-hydroxyglutaric aciduria and brain malignant tumors: a predisposing condition?
Neurology. 2004 May 25;62(10):1882-4.(Case Report, Abstract)


Overall Management


D Frappaz, O Chinot, A Bataillard, M Ben Hassel, L Capelle, S Chanalet, M Chatel, D Figarella-Branger, Y Guegan, J Guyotat, K Hoang-Xuan, E Jouanneau, F Keime-Guibert , C Laforêt, C Linassier, H Loiseau, JP Maire, P Menei, S Rousmans, M Sanson, MP Sunyach
Summary version of the Standards, Options and Recommendations for the management of adult patients with intra-cranial glioma (2002)
Electronic Journal of Oncology, 2003, 1, 115-128. (Review Article, Reference & Full Text)

Ralte AM, Rao S, Sharma MC, Suri A, Gaikwad S, Sarkar C
Myxopapillary ependymoma of the temporal lobe--report of a rare case of temporal lobe epilepsy
Clin Neuropathol. 2004 Mar-Apr;23(2):53-8. (Case Report, Abstract)


Treatment


Benedetti S, Bruzzone MG, Pollo B, DiMeco F, Magrassi L, Pirola B, Cirenei N, Colombo MP, Finocchiaro G
Eradication of rat malignant gliomas by retroviral-mediated, in vivo delivery of the interleukin 4 gene
Cancer Res. 1999 Feb 1;59(3):645-52.

Buklina SB
Impairments in premorbid knowledge recall in patients with hemispheric and intraventricular brain damage
Neurosci Behav Physiol. 2003 Nov;33(9):933-8.  

M. Raphael Pfeffer, Mark L. Levitt, Dan Aderka
Gefitinib in Recurrent Glioblastoma
Journal of Clinical Oncology, Vol 22, No 13 (July 1), 2004: pp. 2755. 

Jeremy N. Rich, Henry S. Friedman, James B. Powell, Jr, Janet E. Dancey
In Reply
Journal of Clinical Oncology, Vol 22, No 13 (July 1), 2004: pp. 2755-a-2756. 

Jeremy N. Rich, David A. Reardon, Terry Peery, Jeannette M. Dowell, Jennifer A. Quinn, Kara L. Penne, Carol J. Wikstrand, Lauren B. Van Duyn, Janet E. Dancey, Roger E. McLendon, James C. Kao, Timothy T. Stenzel, B.K. Ahmed Rasheed, Sandra E. Tourt-Uhlig, James E. Herndon, II, James J. Vredenburgh, John H. Sampson, Allan H. Friedman, Darell D. Bigner, Henry S. Friedman
Phase II Trial of Gefitinib in Recurrent Glioblastoma
Journal of Clinical Oncology, Vol 22, No 1 (January 1), 2004: pp. 133-142 

bottom


HOME | Detection | Diagnosis | Epidemiology | Etiology & Pathogenesis | Integrative Medicine | Overall Mngt & Case Reports | Prevention | Prognosis | Psychosocial Aspects | Treatment 
About BrainLife
| BL Newsletter |
Children's Corner | E-mail Alerts | Journals | Patients & Caregivers | Search | Stem Cells | WHO Classification | SITEMAP